News

bjo.bmj2d
A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab - British Journal of Ophthalmology
Background To develop a model of the pharmacokinetics of vascular endothelial growth factor (VEGF-A) determined in samples of aqueous humour from patients with neovascular age-related macular ...
BMJ4d
Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis - BMJ Open
Objective To examine healthcare resource utilisation (HRU) and direct medical costs for patients with diabetic macular oedema (DME) treated with antivascular endothelial growth factor (anti-VEGF) in ...